Yahoo
Swiss - Delayed Quote CHF

Santhera Pharmaceuticals Holding AG (SANN.SW)

15.32 -0.28 (-1.79%)
At close: October 30 at 5:30:30 PM GMT+1
View in AlphaSpace Currency in CHF All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
101,502
77,185
39,117
103,414
7,473
Cost of Revenue
59,905
62,011
15,534
3,235
3,592
Gross Profit
41,597
15,174
23,583
100,179
3,881
Operating Expense
50,329
52,786
56,734
49,018
55,857
Operating Income
-8,732
-37,612
-33,151
51,161
-51,976
Net Non Operating Interest Income Expense
-17,478
-11,385
-7,784
-20,910
-20,342
Pretax Income
-31,789
-49,051
-41,662
54,820
-70,616
Tax Provision
141
185
312
38
460
Net Income Common Stockholders
-31,930
-49,236
-41,974
54,782
-71,076
Diluted NI Available to Com Stockholders
-31,930
-49,236
-41,974
54,782
-71,076
Basic EPS
-2.24
-3.78
-3.69
5.18
-11.67
Diluted EPS
-2.24
-3.78
-3.69
5.01
-11.67
Basic Average Shares
13,786.63
13,014.63
11,387.07
10,578.75
6,092.73
Diluted Average Shares
13,786.63
13,014.63
11,387.07
10,923.66
6,092.73
Total Operating Income as Reported
-8,730
-37,612
-33,110
68,844
-51,976
Rent Expense Supplemental
--
--
--
--
165
Total Expenses
110,234
114,797
72,268
52,253
59,449
Net Income from Continuing & Discontinued Operation
-31,930
-49,236
-41,974
54,782
-71,076
Normalized Income
-29,315.80
-51,839.03
-39,114.53
29,082.83
-72,620.97
Interest Income
54
409
929
506
0
Interest Expense
17,294
11,556
7,776
21,314
20,189
Net Interest Income
-17,478
-11,385
-7,784
-20,910
-20,342
EBIT
-14,495
-37,495
-33,886
76,134
-50,427
EBITDA
-8,796
-31,815
-28,240
79,178
-40,569
Reconciled Cost of Revenue
59,905
62,011
15,534
3,235
3,592
Reconciled Depreciation
5,699
5,680
5,646
3,044
9,858
Net Income from Continuing Operation Net Minority Interest
-31,930
-49,236
-41,974
54,782
-71,076
Total Unusual Items Excluding Goodwill
-4,357
3,238
-3,557
25,717
1,924
Total Unusual Items
-4,357
3,238
-3,557
25,717
1,924
Normalized EBITDA
-4,439
-35,053
-24,683
53,461
-42,493
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,742.80
634.97
-697.53
17.83
379.03
12/31/2022 - 11/3/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: